Dissociatives

Dissociative drugs represent a class of psychoactive substances characterised by their ability to disrupt the normal processes of perception, memory, and consciousness. These drugs primarily act by inhibiting the actions of the neurotransmitter glutamate on the N-methyl-D-aspartate (NMDA) receptor, which plays a key role in mood regulation, perception of pain, and memory function. As a result, users often experience altered states of reality and consciousness, along with impaired cognitive function.

Originally developed for medical use as anaesthetics or pain relievers, some dissociative drugs, such as ketamine, have legitimate therapeutic applications. However, these substances have increasingly been misused recreationally. This misuse can manifest in various forms, from snorting to injection, leading to a range of effects from mild perceptual distortions to severe hallucinations and cognitive impairment.

The impact of dissociative drugs is not uniform and can vary based on the specific substance, dosage, method of consumption, and individual physiological factors. They can produce experiences commonly described as “dissociative,” in which users feel detached from their own body or reality, akin to being in a dream-like or trance-like state. This disruption of normal brain function can have both short-term and long-term implications for users, ranging from immediate sensory distortions to potential long-term damage to mental health and cognitive abilities.

Medical professionals, lawmakers, and the public need to understand the multifaceted effects of dissociative drug use fully. While some dissociative drugs have therapeutic potential, particularly in treating conditions like depression and post-traumatic stress disorder (PTSD), the adverse effects cannot be ignored. The dual nature of dissociative drugs as both potential medical treatments and agents of abuse complicates their legal status and societal impact, making education and research in this area particularly critical.

Therefore, understanding the short-term and long-term effects serves as a foundational step in addressing the broader implications surrounding the use and misuse of these complex substances.

Dissociative drugs are a category of psychoactive substances that alter perceptions, emotions, and consciousness by disrupting the action of glutamate, a neurotransmitter in the brain that influences cognition, memory, and emotion. By acting on the NMDA (N-methyl-D-aspartate) receptors, these drugs can produce a range of experiences, from mild dissociation and numbness to more severe hallucinations and complete detachment from reality.

Dissociative drugs are generally classified based on their chemical structure and mechanism of action on neurotransmitter systems. Here are the main classes:

• Arylcyclohexylamines: Includes drugs like ketamine and phencyclidine (PCP). These substances typically act as NMDA receptor antagonists.
• Dissociative Anaesthetics: Examples include nitrous oxide (‘laughing gas’). These are used in medical settings for their anaesthetic effects but can be abused for their dissociative properties.
• Dextromethorphan (DXM): Commonly found in over-the-counter cough medications, DXM has dissociative effects when consumed in large quantities.
• Salvinorin A: Found in the Salvia divinorum plant, it acts on kappa opioid receptors rather than NMDA receptors but still produces dissociative effects.

The classification is significant because it offers insights into the drug’s potential medical uses, its abuse potential, and the legal restrictions placed upon it. For instance, ketamine, under the arylcyclohexylamines class, is used in medical settings for its anaesthetic properties and is currently under research for its potential antidepressant effects. Meanwhile, substances like PCP have been largely discontinued from medical use due to their high abuse potential and are illegal in many jurisdictions.

Understanding the classification is vital for both clinicians and law enforcement agencies. It helps clinicians prescribe these drugs responsibly and enables lawmakers to legislate effectively, balancing potential medical benefits against risks of abuse and societal harm.

• Ketamine: Originally developed as an anaesthetic and pain reliever.
• PCP (Phencyclidine): Known for its hallucinogenic and neurotoxic effects.
• DXM (Dextromethorphan): Found in over-the-counter cough medications.
• Nitrous Oxide: Commonly known as “laughing gas,” used in dental procedures and recreationally.
• Salvia Divinorum: Although not medically approved, it is being studied for its potential therapeutic effects, particularly in psychiatry.
• Methoxetamine (MXE): A derivative of ketamine, MXE is often touted as a safer alternative, although it has similar risks and is not medically approved.
• Tiletamine: Often used in veterinary medicine, it has similar effects to ketamine but is not approved for human use.

Physical Effects

• Respiratory Depression: One of the most serious risks is respiratory depression, where the drug slows down the individual’s breathing rate, potentially leading to respiratory failure or death in severe cases.
• Sedation and Drowsiness: The primary intended effect is sedation, which can impair physical coordination and reaction time, making driving extremely dangerous.
• Gastrointestinal Issues: Long-term use or abuse of sedatives can lead to constipation, nausea, and vomiting.
• Dependence and Withdrawal: Physical dependency can develop, leading to withdrawal symptoms like seizures and tremors upon cessation.
• Cardiovascular Effects: Some sedatives may lead to hypotension (low blood pressure) and bradycardia (slowed heart rate), particularly in higher doses.
• Liver Damage: Chronic use of sedatives can put a strain on the liver, which metabolises these drugs. Over time, this can lead to liver dysfunction.

Psychological Effects

• Reduced Anxiety: Sedatives are often effective in reducing feelings of anxiety and inducing a sense of calm, which is one of their primary medical uses.
• Euphoria: Some individuals report feeling euphoric when taking sedatives, which can contribute to their potential for abuse.
• Cognitive Impairment: Memory loss, impaired judgement, and reduced cognitive function can occur, particularly at high doses or when the drug is abused.
• Depression and Mood Swings: Long-term use can result in mood disorders, including depression and severe mood swings.
• Psychological Dependence: A dependence can form, leading individuals to believe they cannot function or handle stress without the medication, thus perpetuating a cycle of use and abuse.

Short-term Effects

• Analgesia: The pain-relieving effects are immediate but short-lived, making some drugs useful for surgical procedures.
• Elevated Senses: Users might experience heightened senses, including seeing brighter colours and sharper sounds, although these effects are temporary.
• Disorientation: Temporary feelings of confusion and spatial disorientation often occur soon after ingestion or inhalation.
• Motor Incoordination: Short-term use may lead to a sudden and severe lack of coordination, including stumbling or an inability to walk straight.
• Euphoria: An immediate and intense feeling of happiness or excitement may be experienced, which is short-lived.

Long-term Effects

• Cognitive Decline: Prolonged use has been associated with deficits in cognitive function, such as impaired memory and diminished problem-solving skills.
• Dependence and Addiction: Long-term use can lead to physical and psychological dependence, with withdrawal symptoms like anxiety and insomnia.
• Psychological Disorders: Extended use has been linked with the development of mental health conditions, including depression and anxiety disorders.
• Organ Damage: Chronic use can result in damage to vital organs, particularly the kidneys and liver, due to the toxic nature of these drugs.
• Social Implications: Long-term use can also have significant social consequences, including estrangement from friends and family and the possibility of criminal charges.

Whether considering medical applications or grappling with public health implications, a comprehensive understanding of dissociative drugs’ short-term and long-term effects is indispensable for healthcare providers, policymakers, and the public.

Dissociative drugs, although associated with recreational abuse, have some important therapeutic applications. Their unique effects on neurotransmitters and brain function make them candidates for various medical treatments.

• Anaesthesia: Ketamine is commonly used in surgical settings as an anaesthetic agent, especially when other anaesthetics cannot be used. It is particularly useful in situations that require rapid induction and recovery times.
• Pain Management: Ketamine and nitrous oxide are used for their analgesic effects, particularly for treating pain that does not respond well to opioids. They are often used for chronic pain conditions and in palliative care.
• Treatment-Resistant Depression: Recent research has shown that low doses of ketamine can offer rapid relief from symptoms of depression that do not respond to traditional antidepressants.
• Post-Traumatic Stress Disorder (PTSD): Preliminary studies indicate that ketamine could be useful in treating PTSD by helping to manage acute stress symptoms and improving the effectiveness of exposure therapy.
• Obsessive-Compulsive Disorder (OCD): Some studies suggest that ketamine may have short-term benefits in reducing symptoms of OCD that are resistant to other forms of treatment.

• Ketamine: Originally developed as an anaesthetic, it has become infamous for recreational abuse. Therapeutically, it is used for anaesthesia, pain management, and psychiatric conditions.
• Phencyclidine (PCP): Initially marketed as an anaesthetic but later discontinued due to its severe psychological effects. It has no current medical uses.
• Dextromethorphan (DXM): Commonly found in over-the-counter cough syrups, it has dissociative properties when consumed in large quantities.
• Nitrous Oxide: Also known as ‘laughing gas’, it is used in dental procedures and some pain management settings.
• Salvia Divinorum: Although not medically approved, it is being studied for its potential therapeutic effects, particularly in psychiatry.

Understanding the therapeutic uses and types of dissociative drugs is important for healthcare providers, policy-makers, and the public. It is crucial to strike the right balance between harnessing the medical potential of these drugs and minimising the risk of abuse and other adverse effects.

Ketamine

• Street Names: Special K, K, Kit Kat, Cat Valium.
• Methods of Use: Injected, snorted, or orally ingested.
• Short-term Effects: Hallucinations, feelings of detachment, sedation.
• Long-term Effects: Cognitive impairment, bladder issues, dissociative disorder.

PCP

• Street Names: Angel Dust, Hog, Wack.
• Methods of Use: Smoked, injected, or ingested.
• Short-term Effects: Hallucinations, paranoia, aggressive behaviour.
• Long-term Effects: Memory loss, difficulties with speech and thinking, weight loss.

Tiletamine

• Street Names: Telazol, Tiletamine-Zolazepam.
• Methods of Use:
• Short-term Effects: Analgesia, sedation, hallucinations.
• Long-term Effects: Cognitive impairment, potential for abuse.

Methoxetamine (MXE)

• Street Names: MXE, Mexxy, M-ket.
• Methods of Use: Snorted, swallowed, injected.
• Short-term Effects: Euphoria, hallucinations, dissociation.
• Long-term Effects: Unknown but suspected to include cognitive impairment and bladder issues.

Nitrous Oxide

• Street Names: NOS, Whippets, Laughing Gas.
• Methods of Use:
• Short-term Effects: Euphoria, laughter, light-headedness.
• Long-term Effects: Neurological issues, vitamin B12 deficiency.

Salvia Divinorum

• Street Names: Sally D, Magic Mint, Diviner’s Sage.
• Methods of Use: Chewed, smoked, vaporised.
• Short-term Effects: Visual hallucinations, altered perception, disorientation.
• Long-term Effects: Little is known, but concerns include potential for abuse and cognitive impairment.

Dextromethorphan (DXM)

• Street Names: Robo, Dex, Tussin.
• Methods of Use: Orally ingested.
• Short-term Effects: Euphoria, hallucinations, impaired motor function.
• Long-term Effects: Cognitive impairment, liver damage, potential for abuse.

Understanding the diverse ways through which dissociative drugs can be administered is crucial for both healthcare professionals and users. Each method has its own set of implications related to the onset of effects, intensity, and associated health risks. While some methods may be more socially acceptable or medically approved, others can come with high health risks, including addiction and severe bodily harm. Below are the common routes of administration.

Oral Consumption

Oral intake is a familiar and frequently employed method for administering many kinds of medications, including some dissociative drugs like ketamine, when used in medical settings. The drug is typically consumed in tablet or capsule form and swallowed. It then proceeds through the gastrointestinal system before entering the bloodstream. The liver often metabolises the drug during its journey through the digestive system, influencing the duration and intensity of the drug’s effects. This method is often considered less risky than methods such as injection, but it usually has a slower onset of effects. In the case of misuse, oral consumption can still lead to dependency and other health issues, such as liver damage.

Snorting (Intranasal Administration)

Snorting, also known as intranasal administration, involves inhaling the drug in powdered form through the nostrils. For dissociative drugs like ketamine, this method allows for quick absorption of the substance through the mucous membranes in the nasal passages. The fast onset is one reason users may prefer this method. However, repeated use can significantly damage the nasal passages, including erosion of the mucous membrane. It can also lead to an increased risk of overdose due to the rapid onset of effects and, potentially, dependency.

Smoking

Though less common than other methods, smoking is another way some dissociative drugs like PCP are administered. The substance is often applied to a leafy material like marijuana or tobacco and then smoked. When inhaled, the drug quickly passes through the lungs into the bloodstream, leading to a rapid onset of effects. This method, however, exposes the user to risks associated with smoking, such as lung damage and respiratory issues. The rapid absorption also raises the chances of overdose and dependency.

Injection

Injecting dissociative drugs like ketamine is another method and is often done intramuscularly. This means that the drug is injected directly into muscle tissue. This route of administration leads to an extremely fast onset of effects, often within minutes. However, this method poses several serious risks, including infection at the injection site, transmission of diseases like HIV/AIDS if needles are shared, and a high risk of overdose due to the rapid onset and intensity of effects.

Other Methods

There are also less conventional methods of administering dissociative drugs, including topical application and sublingual (under the tongue) methods. For example, certain types of ketamine can be used topically for medical procedures. Sublingual administration involves placing the drug under the tongue for fast absorption. Each of these alternative methods has its own set of pros and cons. For instance, topical application is often used for localised effects but has a slower onset. In contrast, sublingual administration can be more rapid but may also carry risks of tissue damage if the drug is corrosive.

Dissociative abuse poses a severe threat to both physical and mental well-being due to its complex effects on consciousness and sensory perception. Awareness of the signs, symptoms, and ramifications of misuse can lead to more effective preventive measures and treatments.

Signs of Abuse

• Initial effects: The allure of dissociative often lies in their capacity to create a sense of detachment or altered reality. This may include sensations of floating, distortion of time, and hallucinations.
• Cognitive impact: With extended use, cognitive issues such as memory loss, difficulties in problem-solving, and decreased motor skills can manifest.
• Emotional Symptoms: Chronic use may lead to increased incidents of depression, anxiety, and other emotional health issues.

Consequences of Chronic Use

• Addiction Risk: Though not all dissociative are considered highly addictive, substances like PCP have high abuse potential and can lead to physical dependency.
• Neurological Impact: Chronic use can lead to persistent speech difficulties, memory loss, and even irreversible damage to cognitive functions.
• Physical Harm: Abuse of these substances may lead to high blood pressure, lethal respiratory issues, and, in severe cases, comatose states.

Overdose Symptoms and Management

• Immediate Symptoms: Overdosing on dissociative can manifest in a range of symptoms from seizures to extreme hypertension.
• Intervention Steps: Being aware of the signs of an overdose is crucial for immediate medical intervention. This often includes supportive care and symptom management.

Understanding the risks associated with dissociative abuse is vital not only for individual safety but also for community well-being. These dangers underscore the necessity of awareness, proper education, and accessible treatment avenues for dissociative abuse and addiction.

The legal landscape surrounding dissociative drugs in the UK is delineated by a multitude of laws and regulations designed to oversee the use, possession, and dissemination of these substances. These regulations are intended to weigh the medical potential of certain dissociative against the risks related to misuse and abuse. The framework encompasses both prescription and non-prescription substances and includes varying degrees of penalties and sanctions.

Regulation of Prescription Dissociative

• Controlled Substances: Dissociative like ketamine are regulated under the Misuse of Drugs Act (1971), the Medicines Act (1968), and the Psychoactive Substances Act (2016). These acts ensure that medical professionals adhere to strict guidelines when prescribing these substances.
• Scheduling System: Within these legislative frameworks, dissociatives are classified into different schedules (Class A, B, C) based on their potential for abuse and medical applications. Class A dissociative, such as PCP, are considered the most harmful and carry the highest penalties.
• Prescription Regulations: The UK’s National Health Service (NHS) and other regulatory bodies have specific guidelines for prescribing dissociatives. This includes stringent monitoring and reporting mechanisms to ensure the drugs are not misused or diverted for non-medical purposes.

Illicit Dissociative Laws and Penalties

• Prohibition and Criminalisation: Unlawful possession, sale, or production of dissociatives is criminalised under the Misuse of Drugs Act (1971). For instance, the illegal use or distribution of ketamine, a Class B drug, results in severe penalties, including imprisonment.
• Penalties: Penalties can be quite severe, depending on the class of the drug and the nature of the offence. This can range from fines to imprisonment, with Class A drugs carrying the heaviest sanctions. For example, illegal possession of PCP can result in a lengthy prison sentence and hefty fines.

Understanding the intricate legal framework governing the use of dissociative drugs in the UK is crucial for individuals, healthcare providers, and the public. This understanding ensures responsible management and use of these substances within the confines of the law.

Understanding how to navigate the world of dissociative drugs requires an in-depth grasp of harm reduction and safe use guidelines. Whether for medical or recreational purposes, these practices are pivotal in reducing risks and fostering a culture of safety and responsibility.

Dosage and Frequency Guidelines

• Medical Use: For those using dissociative drugs like ketamine for medical reasons, strictly following prescribed dosages and frequency is vital. Not adhering to medical advice can result in severe side effects, or, worse, dependency issues.
• Recreational Use: If you’re using dissociatives recreationally, it’s crucial to understand their potency and effects. Lack of knowledge can lead to overdose, resulting in dangerous health complications like dissociative stupor or seizures.

Safe Use Practices

• Drug Mixing: Co-administering dissociatives with other substances, such as alcohol or opioids, can result in fatal interactions. These interactions can amplify the sedative effects, leading to respiratory failure.
• Route of Administration: Choosing safer methods like oral consumption over riskier routes such as intravenous injection can mitigate the risks associated with potential infections and overdose.
• Purity and Source: Knowing the purity and source of your dissociative drug can help you gauge its safety. Impure drugs or those from unreliable sources can contain dangerous contaminants.
• Clean Equipment: Utilising sterile equipment for drug administration can dramatically lower the risk of infections, thereby mitigating one of the significant dangers associated with intravenous drug use.

Resources for Help and Support

• Addiction Treatment Centres: Multiple facilities provide medical and psychological support for those struggling with dissociative drug addiction. These centres often offer detoxification and cognitive behavioural therapy.
• Community Support Groups: These are essential for long-term recovery and can offer emotional support, which is invaluable for people recovering from dissociative drug misuse.
• Online Forums: Digital platforms allow users to share experiences, seek advice, and offer moral support to each other, making them a valuable tool for those aiming for safer drug use or complete recovery.

Safer Consumption Tips

• Start with a Small Dose: If the drug is new to you or from a different source, always start with a minimal dose to assess your body’s response.
• Stay Hydrated and Nourished: Adequate hydration and nutrition can help alleviate some negative side effects of dissociative drug use, such as nausea or dizziness.
• Rest and Recovery: Allowing your body ample time to recover between doses can significantly reduce the risk of accumulating negative side effects and developing dependency issues.

Adhering to these harm reduction and safe use guidelines can drastically lower the risks and potential harm linked to dissociative drug use, thereby fostering a safer community.

Understanding the complexities surrounding dissociative drugs is a pivotal exercise in public health, social policy, and individual safety. Dissociative drugs, including substances like ketamine, PCP, and DXM, operate on the brain’s neurotransmitters to induce a range of effects that include altered perceptions, distorted reality, and, sometimes, complete dissociation from the self and environment. While some of these substances, such as ketamine, have legitimate medical uses, primarily as anaesthetics, their misuse can lead to a plethora of health issues, both psychological and physiological.

The misuse and abuse of dissociative drugs have multiple and far-reaching consequences. Physiologically, these drugs can lead to high blood pressure, respiratory issues, and even seizures in extreme cases. Psychologically, there’s a risk of paranoia, hallucinations, and lasting cognitive impairment. This makes the subject of abuse particularly problematic from a public health perspective. Importantly, beyond the individual, the ripple effects of dissociative drug abuse can have a significant social impact, affecting families, communities, and healthcare systems.

When it comes to legality, jurisdictions have attempted to control the use and distribution of these drugs. For instance, the UK has classified drugs like ketamine under the Misuse of Drugs Act (1971), underlining its potential for abuse despite its medical utility. Such legal frameworks aim to strike a delicate balance between permitting medical uses and preventing widespread misuse and abuse. Nevertheless, these frameworks can sometimes fall short due to factors such as illegal trafficking and the emergence of new synthetic versions of these drugs.

In the face of these challenges, harm reduction strategies and safe use guidelines serve as important tools for managing the risks associated with dissociative drugs. Adherence to dosage and frequency guidelines, caution against mixing substances, and advocating for clean equipment and safer routes of administration are crucial steps in mitigating the associated risks.

In sum, dissociative drugs present a multifaceted challenge that demands a multipronged response. The medical utility of certain dissociative drugs adds another layer of complexity to the issue, making a blanket criminalisation approach problematic. This underscores the need for a nuanced strategy that considers the medical, social, and individual dimensions of dissociative drug use. Public awareness campaigns, education, and accessible treatment options are integral to this strategy. As the understanding of these substances grows, it becomes increasingly imperative for all stakeholders involved—lawmakers, healthcare providers, and the public—to stay informed and engaged in a collective effort to manage and mitigate the associated risks and challenges.

Alcohol and Drug Foundation. (n.d.). Drug Facts: Dissociatives. Available at: https://adf.org.au/drug-facts/dissociatives/

New York City Government. (n.d.). Health Topics: Dissociative Drugs. Available at: https://www.nyc.gov/site/doh/health/health-topics/dissociative-drugs.page

National Institute on Drug Abuse. (n.d.). Hallucinogens and Dissociative Drugs. Available at: https://nida.nih.gov/sites/default/files/hallucinogensrrs.pdf

Mind. (n.d.). About Dissociation and Dissociative Disorders. Available at: https://www.mind.org.uk/information-support/types-of-mental-health-problems/dissociation-and-dissociative-disorders/about-dissociation/

ScienceDirect. (n.d.). Topics in Medicine and Dentistry: Dissociative Disorder. Available at: https://www.sciencedirect.com/topics/medicine-and-dentistry/dissociative-disorder

McLean Hospital. (n.d.). Essential Knowledge on DID. Available at: https://www.mcleanhospital.org/essential/did

American Addiction Centers. (n.d.). Dissociative Disorders. Available at: https://americanaddictioncenters.org/dissociative-disorders

Cleveland Clinic. (n.d.). Diseases: Dissociative Disorders. Available at: https://my.clevelandclinic.org/health/diseases/17749-dissociative-disorders

American Psychiatric Association. (n.d.). What are Dissociative Disorders? Available at: https://www.psychiatry.org/patients-families/dissociative-disorders/what-are-dissociative-disorders

National Alliance on Mental Illness. (n.d.). About Mental Illness: Dissociative Disorders. Available at: https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Dissociative-Disorders

Addiction Group. (n.d.). Psychedelics: Dissociatives. Available at: https://www.addictiongroup.org/drugs/psychedelics/dissociatives/

ScienceDirect. (n.d.). Topics in Chemistry: Dissociative Anaesthetic Agent. Available at: https://www.sciencedirect.com/topics/chemistry/dissociative-anesthetic-agent

Renaissance Recovery. (n.d.). Dissociative Drugs. Available at: https://www.renaissancerecovery.com/dissociative-drugs/

Cambridge University Press. (n.d.). BJPsych Open: Biomarkers of Dissociation. Available at: https://www.cambridge.org/core/journals/bjpsych-open/biomarkers-of-dissociation-themed-series